INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 98 filers reported holding INSYS THERAPEUTICS INC NEW in Q1 2019. The put-call ratio across all filers is 1.66 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $1,000 | -50.0% | 200 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $2,000 | +100.0% | 200 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $1,000 | 0.0% | 200 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $1,000 | -50.0% | 200 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $2,000 | 0.0% | 200 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $2,000 | -33.3% | 200 | 0.0% | 0.00% | -50.0% |
| Q2 2017 | $3,000 | +50.0% | 200 | 0.0% | 0.00% | +100.0% |
| Q1 2017 | $2,000 | 0.0% | 200 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $2,000 | 0.0% | 200 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $2,000 | -33.3% | 200 | 0.0% | 0.00% | -50.0% |
| Q2 2016 | $3,000 | 0.0% | 200 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $3,000 | -50.0% | 200 | 0.0% | 0.00% | -50.0% |
| Q4 2015 | $6,000 | 0.0% | 200 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $6,000 | -14.3% | 200 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $7,000 | +16.7% | 200 | +100.0% | 0.00% | 0.0% |
| Q1 2015 | $6,000 | -33.3% | 100 | -66.7% | 0.00% | -60.0% |
| Q2 2014 | $9,000 | – | 300 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 5,406,844 | $52,014,000 | 0.66% |
| ETF MANAGERS GROUP, LLC | 282,268 | $3,255,000 | 0.24% |
| Mirae Asset Global Investments Co., Ltd. | 1,470,996 | $14,151,000 | 0.19% |
| Financial Gravity Companies, Inc. | 4,467 | $42,000 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 67,200 | $646,000 | 0.04% |
| TCI Wealth Advisors, Inc. | 7,766 | $75,000 | 0.03% |
| Freedom Investment Management, Inc. | 64,741 | $623,000 | 0.03% |
| GAM Holding AG | 83,940 | $808,000 | 0.02% |
| SFMG, LLC | 11,994 | $115,000 | 0.02% |
| SHELL ASSET MANAGEMENT CO | 95,127 | $915,000 | 0.02% |